Legal Opinion
Ganem v. Invivo Therapeutics Holdings Corp.
Court of Appeals for the First Circuit
Decided January 9, 2017No. 15-1544PPublishedCited by 28 opinions
1Opinion of the Court
LIPEZ, Circuit Judge.
Following a drop in the share price of InVivo Therapeutics Holdings Corporation’s (“InVivo”) common stock, investors filed suit against the company and its former chief executive officer (“CEO”), Frank Reynolds, alleging securities fraud in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”), 15 U.S.C. §§ 78j(b) and 78t(a), as well as the Securities and Exchange Commission’s (“SEC”) Rule 10b-5, 17 C.F.R. § 240.10b-5. On behalf of himself and a putative class of shareholders, lead plaintiff Edmond Ganem (“Ganem”) alleges that…
2Cases cited10 opinions
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Matrixx Initiatives, Inc. v. SiracusanoSupreme Court of the United States · 2011
- Securities & Exchange Commission v. TamboneCourt of Appeals for the First Circuit · 2010
- Denny v. BarberCourt of Appeals for the Second Circuit · 1978
- Gross v. Summa Four, Inc.Court of Appeals for the First Circuit · 1996
5 more not listed; retrieve them via the Exa API.
3Cited by28 opinions
- Ponsa-Rabell v. Santander Securities, LLCCourt of Appeals for the First Circuit · 2022
- Yan v. ReWalk Robotics Ltd.Court of Appeals for the First Circuit · 2020
- City of Miami Fire Fighters & Police Ofcs Ret Tr v. CVS Health CorporationCourt of Appeals for the First Circuit · 2022
- Karth v. Keryx Biopharmaceuticals, Inc.Court of Appeals for the First Circuit · 2021
- Pension Trust v. J.Jill, Inc.District Court, District of Columbia · 2018
23 more not listed; retrieve them via the Exa API.